Sorry!! The article you are trying to read is not available now.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Eli Lilly (NY: LLY)
86.87 USD  +0.51 (+0.59%)
Streaming Delayed Price  /  Updated: 10:00 AM EDT, Oct 20, 2017  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 300,691
Open 86.52
Bid (Size) 86.84 (100)
Ask (Size) 86.89 (100)
Prev. Close 86.36
Today's Range 86.33 - 86.89
52wk Range 65.66 - 89.09
Shares Outstanding 1,100,988,944
Dividend Yield 2.39%
Performance
YTD
+16.45%
+16.45%
1 Month
+6.29%
+6.29%
3 Month
+2.50%
+2.50%
6 Month
+6.02%
+6.02%
1 Year
+10.58%
+10.58%
Featured News
More News
Eli Lilly names Joshua Smiley as new CFO
The staff turnover comes at a time of change for the drugmaker, which announced layoffs earlier this month. Read More
category LLY , Pharmaceuticals , Medical Products , and 4 more.
from MarketWatch
What you don’t know about Martin Shkreli — his investing tips and strategies
The ‘pharma bro’ might be mired in controversy, but he has valuable investing insights, writes Michael Brush. Read More
category BMY , AAPL , RHHBY , and 17 more.
from MarketWatch
Featured News
Read More
This market leader was the most-purchased stock by hedge funds last quarter
category NFLX , Computer Hardware , Retail , and 28 more.
from MarketWatch
Health-care fund managers say a spike in drugs and devices will produce big returns
category CELG , Medical Products , SPX , and 33 more.
from MarketWatch
Here’s why Apple, Facebook and the gang are not going to take down this market
category General , DD , Industrial , and 69 more.
from MarketWatch
S&P futures fight for direction, as Alphabet sets downbeat tone
category COMP , UTX , Manufacturing , and 33 more.
from MarketWatch
Eli Lilly will co-develop autoimmune disease therapy under $150 million deal with Nektar
category Biotechnology , Medical Products , Industrial Products & Services , and 10 more.
from MarketWatch
Bipartisan political squabbling over drug prices has already cost biotech companies $21 billion
category AMGN , BMY , Commodities , and 22 more.
from MarketWatch
More News
Read More
Lilly and CureVac Announce Global Collaboration to Develop mRNA Cancer Vaccines
from PR Newswire
Lilly Declares Fourth-Quarter 2017 Dividend
from PR Newswire
Rapidly Progressing Advanced Non-Small Cell Lung Cancer Patients Shown to Benefit in New CYRAMZA® (ramucirumab) Phase 3 Subgroup Analysis
from PR Newswire
How Allergan's 'Public Relations Backlash' Deepened This Week
from Investor's Business Daily
UPDATE 3-Novo Nordisk takes aim at Eli Lilly with U.S. backing of new diabetes drug
category companyNews
from Reuters: Company News
INSIGHT-China biotech's 'coming out party' masks long road ahead
category companyNews
from Reuters: Company News
UPDATE 1-U.S. FDA panel backs approval of Novo Nordisk diabetes drug
category companyNews
from Reuters: Company News
Boosted By Keytruda, Citi Upgrades Merck To Buy For The First Time Ever
category Citi , Pdx , AZN , and 13 more.
from Benzinga
Eli Lilly to collaborate with Germany's CureVac on cancer vaccines
category companyNews
from Reuters: Company News
10 Stunning Numbers You Need to Know About Breast Cancer
category CLDX , LLY
from Motley Fool
UPDATE 1-Trump favors ex-pharma executive Azar for health secretary -Politico
category companyNews
from Reuters: Company News
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial

WHAT'S POPULAR IN THE VILLE

1
Gold/Silver vs. Bitcoin Comparisons: A No-Brainer... or Brainless?
2
The Largest Growing Medical Marijuana Market: Arthritis Suffers
3
The Largest Growing Medical Marijuana Market: Arthritis Suffers
4
EURUSD Recovers, Eyes Further Bull Pressure Towards 1.1879 Region
5
The Best Technology Industries to Invest In 2018